Samsung Launches AccE Glass-Free Detector for X-Ray Imaging

Representing the company’s philosophy of “relentless innovation,” this new solution provides a comfortable image experience for both patients and users DANVERS, Mass.–(BUSINESS WIRE)–To optimize work efficiency and portability, Samsung has introduced a new flagship detector, the AccE Glass-Free Detector. The AccE Glass-Free Detector recently received 510(k) clearance from the U.S. Food and Drug Administration for … [Read more…]

More Precise Diagnoses, Efficient Monitoring and Comfortable Patient Experiences are Hallmarks of Advanced Medical Technologies in the New HealthAlliance Hospital

Executives from WMCHealth and Philips Sign Ceremonial Agreement Symbolizing Technology Partnership KINGSTON, N.Y.–(BUSINESS WIRE)–HealthAlliance Hospital, a member of the Westchester Medical Center Health Network, and Royal Philips (NYSE: PHG, AEX: PHIA) a global leader in health technology, held a ceremonial signing today commemorating a partnership that is delivering advanced medical technologies to the new HealthAlliance … [Read more…]

Real-World Evidence Solutions Global Market Report 2022: Need for Precise and Clear Information About the Safety and Efficacy of New Products Driving Adoption – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Real-World Evidence Solutions Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” report has been added to ResearchAndMarkets.com’s offering. The global real-world evidence solutions market size reached US$ 1.41 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 3.01 Billion by 2027, exhibiting a CAGR of 13.47% … [Read more…]

Hugel Aesthetics Receives FDA Acceptance of BLA Resubmission for LetibotulinumtoxinA for Injection for Glabellar Lines

PDUFA goal date set for April 6, 2023 NEWPORT BEACH, Calif.–(BUSINESS WIRE)–Hugel America, Inc. (Hugel Aesthetics) announced today the acceptance of its Biologics License Application for letibotulinumtoxinA, by the U.S. Food and Drug Administration (“FDA”). The FDA considered the resubmission a Class 2 response and has assigned a April 6, 2023 action date per the … [Read more…]

Humanetics Corporation Presents at the 68th Annual International Radiation Research Society Meeting

Presentations provided an update on a novel solid-dosage formulation of BIO 300 MINNEAPOLIS–(BUSINESS WIRE)–Humanetics Corporation (Humanetics) presented data related to its new drug candidate, BIO 300, at the 68th Annual International Radiation Research Society Meeting, October 16-19, 2022. Michael Kaytor, PhD, Vice President of Research and Development for Humanetics, presented data related to BIO 300 … [Read more…]

Iron Bow Technologies Selected to Support VA’s $650M Accelerating VA Innovation and Learning Program

HERNDON, Va.–(BUSINESS WIRE)–#IT—Iron Bow Technologies, the leading technology solutions provider to government, healthcare and commercial markets, has been awarded a five-year contract from the Department of Veterans Affairs (VA) to deliver transformative healthcare solutions that advance VHA’s mission of providing world-class care to our nation’s Veterans. The Accelerating VA Innovation and Learning (AVAIL) contract, with … [Read more…]

HighTide Therapeutics Announces Presentations at The Liver Meeting® 2022

ROCKVILLE, Md. & SHENZHEN, China–(BUSINESS WIRE)–HighTide Therapeutics, Inc. (“HighTide”), a clinical-stage biopharmaceutical company developing novel multifunctional therapies for metabolic and digestive diseases, today announced that two abstracts related to its HTD1801 development program will be presented at The Liver Meeting® of the American Association for the Study of Liver Diseases (AASLD), in Washington, DC (November … [Read more…]

Clinics Across Florida, New Jersey & California Advancing Mental Health in Underserved Communities – Awarded Funding from Teva Pharmaceuticals, Direct Relief and NAFC

Community Routes: Access to Mental Healthcare, a partnership between Direct Relief, the National Association of Free and Charitable Clinics, and Teva Pharmaceuticals, provides awards to support clinics expanding access to mental health services across three states SANTA BARBARA, Calif. & PARSIPPANY, N.J.–(BUSINESS WIRE)–Teva Pharmaceuticals, the National Association of Free and Charitable Clinics (NAFC) and Direct … [Read more…]

athenahealth MSSP ACO Customers Generated $233 Million in Shared Savings for CMS in 2021

ACOs using athenahealth’s Population Health solution performed better than industry average on several key metrics, including average quality score1 WATERTOWN, Mass.–(BUSINESS WIRE)–athenahealth, Inc., a leading provider of network-enabled software and services for medical groups and health systems nationwide, today announced that Accountable Care Organization (ACO) customers using its Population Health solution generated a total of … [Read more…]

Verily and Crohn’s & Colitis Foundation Expand Strategic Partnership to Establish Novel Registry of Patients With Inflammatory Bowel Disease (IBD) 

The partnership’s first-of-its-kind participant-centered model will be critical in advancing clinical IBD research SOUTH SAN FRANCISCO, Calif. & NEW YORK–(BUSINESS WIRE)–Verily, an Alphabet company focused on precision health, and the Crohn’s & Colitis Foundation, a non-profit organization dedicated to finding cures for Crohn’s disease and ulcerative colitis and to improving the quality of life of … [Read more…]